Thermo Fisher Scientific Inc.
corporate_fare Company Profile
Thermo Fisher Scientific Inc. (NYSE:TMO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for TMO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-31, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for TMO spans 10-Q, 8-K, DEFA14A, DEF 14A.
Recent high-impact activity:
- Thermo Fisher Q2 2026: Revenue Reaches $11.99B, Clario Deal Closes, Microbiology Unit Sold
- Thermo Fisher Q2 Revenue Reaches $11.99B, Adjusted EPS Hits $6.03, and Guidance Is Raised
- Thermo Fisher Sees Broad-Based Customer Activity Strengthening in Q2
- Shareholders Reject Thermo Fisher's Executive Compensation Plan
- Thermo Fisher Projects 7% Annual Organic Revenue Growth, Low-Teens EPS Growth Long-Term
Financial Snapshot
Short Interest & Short Volume
2.74 days to coverFINRA reported short interest of 5,019,933 shares in TMO as of the September 15, 2026 settlement, a 11.8% decrease from the prior period — about 2.7 days to cover at its recent average daily volume. On October 2, 2026, 53.3% of TMO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.